Sign in

CIK 0001818794

  • Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364883909
Phone
+1 781-786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
Open-market buys, last 90 days
$40,000
in 1 filing
Open-market sales, last 90 days
$421,679
in 7 filings, $422K under 10b5-1 plans

Net −$381,679. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-05 Lubner David Charles Director Grant or award · Stock option (right to buy) +35,152 35,152
2026-04-24 Lubner David Charles Director Gift −53,625 0
2025-05-30 Lubner David Charles Director Grant or award · Stock option (right to buy) +35,000 35,000
2024-05-22 Lubner David Charles Director Grant or award · Stock option (right to buy) +25,133 25,133
2023-05-24 Lubner David Charles Director Grant or award · Stock Option (right to buy) +24,900 24,900
2022-07-05 Lubner David Charles Director Grant or award · Stock Option (right to buy) +7,222 7,222
2022-06-03 Lubner David Charles Director Grant or award · Stock Option (right to buy) +19,596 19,596
2021-05-26 Lubner David Charles Director Grant or award · Stock Option (right to buy) +19,596 19,596
2020-09-21 Lubner David Charles Director Conversion +53,625 53,625
2020-09-21 Lubner David Charles Director Conversion · Series B Preferred Stock −177,872 0
2020-08-07 Lubner David Charles Director Purchase · Series B Preferred Stock +177,872 $2.81 $500K 177,872
2020-07-31 Lubner David Charles Director Grant or award · Stock Option (right to buy) +11,156 11,156
2020-07-31 Lubner David Charles Director Grant or award · Stock Option (right to buy) +14,444 14,444

Page 1 of 1 · 13 trades